237 related articles for article (PubMed ID: 31613226)
1. The prognostic value of YAP1 on clinical outcomes in human cancers.
Wu Y; Hou Y; Xu P; Deng Y; Liu K; Wang M; Tian T; Dai C; Li N; Hao Q; Song D; Zhou LH; Dai Z
Aging (Albany NY); 2019 Oct; 11(19):8681-8700. PubMed ID: 31613226
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
[TBL] [Abstract][Full Text] [Related]
3. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.
Zhang L; Song X; Li X; Wu C; Jiang J
Biomed Res Int; 2018; 2018():4039173. PubMed ID: 30539010
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of Yes-associated protein 1 in patients with colorectal cancer. A systematic review and meta-analysis.
Zhang H; Yin M; Hu Y; Jiang M; Lu M; Wu Y
Rev Esp Enferm Dig; 2024 Mar; 116(3):148-156. PubMed ID: 36177818
[TBL] [Abstract][Full Text] [Related]
5. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI
PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
Zhu L; Ma G; Liu J; Deng Y; Wu Q; Chen W; Zhou Q
Medicine (Baltimore); 2019 Apr; 98(16):e15069. PubMed ID: 31008931
[TBL] [Abstract][Full Text] [Related]
7. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
8. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract][Full Text] [Related]
9. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.
Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S
Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.
Zhang P; Hu P; Shen H; Yu J; Liu Q; Du J
Eur J Clin Invest; 2014 Nov; 44(11):1072-94. PubMed ID: 25257753
[TBL] [Abstract][Full Text] [Related]
13. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Zhou Q; Bauden M; Andersson R; Hu D; Marko-Varga G; Xu J; Sasor A; Dai H; Pawłowski K; Said Hilmersson K; Chen X; Ansari D
J Transl Med; 2020 Feb; 18(1):77. PubMed ID: 32054505
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
15. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Asian Pac J Cancer Prev; 2013; 14(2):645-9. PubMed ID: 23621212
[TBL] [Abstract][Full Text] [Related]
17. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.
Guichet PO; Masliantsev K; Tachon G; Petropoulos C; Godet J; Larrieu D; Milin S; Wager M; Karayan-Tapon L
J Pathol; 2018 Oct; 246(2):205-216. PubMed ID: 30009411
[TBL] [Abstract][Full Text] [Related]
18. Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.
Meerang M; Bérard K; Friess M; Bitanihirwe BK; Soltermann A; Vrugt B; Felley-Bosco E; Bueno R; Richards WG; Seifert B; Stahel R; Weder W; Opitz I
Mol Oncol; 2016 Oct; 10(8):1255-65. PubMed ID: 27378628
[TBL] [Abstract][Full Text] [Related]
19. Gene Regulation Network of Prognostic Biomarker YAP1 in Human Cancers: An Integrated Bioinformatics Study.
Wu B; Tang X; Ke H; Zhou Q; Zhou Z; Tang S; Ke R
Pathol Oncol Res; 2021; 27():1609768. PubMed ID: 34257617
[No Abstract] [Full Text] [Related]
20. Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis.
Zhang C; Zhou C; Xu J; Xue S
Dis Markers; 2022; 2022():8443932. PubMed ID: 35126792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
